Carindacillin (sodium)

Carindacillin (Carbenicillin indanyl) sodium is an orally active and broad-spectrum antimicrobial agent. Carindacillin sodium can be hydrolyzed to Carbenicillin in vivo. Carindacillin sodium can be used for the research of urinary-tract infection[1][2].

Product Specifications

CAS Number

[26605-69-6]

Product Name Alternative

Carbenicillin indanyl sodium; CP-15464-2

UNSPSC

12352005

Target

Bacterial

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/carindacillin-sodium.html

Purity

96.73

Solubility

DMSO : 250 mg/mL (ultrasonic)

Smiles

O=C(C(C1=CC=CC=C1)C(OC2=CC=C3C(CCC3)=C2)=O)N[C@H]4[C@](SC(C)5C)([H])N(C4=O)[C@H]5C(O[Na])=O

Molecular Formula

C26H25N2NaO6S

Molecular Weight

516.54

References & Citations

[1]English AR, et, al. Carbenicillin indanyl sodium, an orally active derivative of carbenicillin. Antimicrob Agents Chemother. 1972 Mar;1 (3) :185-91.|[2]Ries KM, et, al. Comparison of carbenicillin indanyl sodium, ampicillin, and cephaloglycin in treatment of urinary-tract infection. J Infect Dis. 1973 May;127:Suppl:148-53.